Atrial natriuretic factor regulation of cyclic GMP levels and steroidogenesis in isolated fasciculata cells of rat adrenal cortex  by Jaiswal, Neelam et al.
Volume 199, number 1 FEBS 3572 April 1986 
Atria1 natriuretic factor regulation of cyclic GMP levels and 
steroidogenesis n isolated fasciculata cells of rat adrenal 
cortex 
Neelam Jaiswal, Aranjiniyil K. Paul, Rama Kant Jaiswal and Rameshwar K. Sharma* 
Department of Biochemistry, University of Tennessee, 894 Union Ave. Memphis, TN 38163, USA 
Received 22 January 1986 
Isolated fasciculata cells of rat adrenal cortex, when incubated with atria1 natriuretic factor (ANF), stimulat- 
ed the levels of cyclic GMP and corticosterone production in a concentration-dependent manner without 
a rise in the levels of cyclic AMP. The ANF-dependent elevation of cyclic GMP was rapid, with a detectable 
increment in 30 s. ANF also stimulated the particulate guanylate cyclase. These results not only indicate 
the coupling of cyclic GMP and corticosterone production with ANF signal, but also demonstrate that, 
like the ACTH signal, cyclic AMP is not the mediator of ANF-induced adrenocortical steroidogenesis. 
Atrial natriuretic factor cyclic GMP Membrane enzyme Guanylate cyclase Steroidogenesis 
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1. INTRODUCTION 
Atria1 natriuretic factor (ANF) is a peptide hor- 
mone that is released from atria and regulates 
sodium, water balance and blood pressure (review 
[l]). Although the presence of ANF receptors in 
tissues like kidney and blood vessels has been 
demonstrated [2-41, the biochemical mechanism 
of its action is not known. Since ANF selectively 
activates particulate guanylate cyclase, the 
possibility exists that cyclic GMP is the second 
messenger of ANF signal transduction [5]. We 
have provided extensive vidence for the mediatory 
role of cyclic GMP in ACTH-induced 
steroidogenesis and for the presence of ACTH- 
dependent particulate guanylate cyclase, in rat 
adrenocortical cells ([6] and references cited 
therein). Recently, atriopeptin has been shown to 
activate selectively particulate guanylate cyclase in 
rat adrenal cortex [7]. This common property of 
the two hormones of activating adrenocortical 
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membrane guanylate cyclase provided us with a ra- 
tionale to scrutinize whether the ANF receptor 
signal, like that of ACTH, is coupled to the pro- 
cess of steroidogenesis n isolated fasciculata cells 
of rat adrenal cortex [8]. The results indicate that 
this indeed was the case. We have discussed the im- 
plications of these findings in relationship to the 
mediatory role of cyclic GMP in steroidogenic 
signal transduction. 
2. MATERIALS AND METHODS 
Isolated fasciculata and adrenocortical car- 
cinoma cell preparations were prepared by the 
trypsin digestion method [8,9]. The cells have been 
thoroughly characterized, morphologically and 
biochemically [9,10]. In general, for one experi- 
ment, adrenal glands from 16 rats or 1.2 g of the 
adrenocortical carcinoma tissue were used, and the 
cells from each adrenal gland (-2 x lo6 cells) or 
the corresponding tumor cells were incubated with 
ANF as described [8]. Assays for cyclic nucleotides 
and steroids were conducted at 10 min and 2 h, 
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respectively [ 111. Steroids were measured 
fluorometrically and expressed as corticosterone. 
Cyclic AMP and cyclic GMP were extracted and 
measured as in [l 11. Results are expressed as the 
mean values (+ SD) of 6 separate determinations 
from 3 different experiments. 
3. RESULTS AND DISCUSSION 
To determine the correlation between the syn- 
thesis of corticosterone and endogenous levels of 
cyclic GMP and cyclic AMP formed in response to 
the varying concentrations of ANF, isolated 
fasciculata cells of rat adrenal cortex were in- 
cubated with a series of concentrations of ANF 
and the levels of corticosterone, cyclic GMP and 
cyclic AMP measured (fig.1). The results indicate 
that ANF raises the levels of cyclic GMP, but not 
of cyclic AMP, in a concentration-dependent man- 
ner with a parallel increase in the production of 
corticosterone. The EDso values of ANF for cyclic 
GMP and corticosterone production were 0.25 x 
10m8 and 10e8 M, respectively. Similar results with 
respect to the elevations of cyclic GMP were 
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Fig.2. (A) Dose response of cGMP formation by ANF in 
isolated adrenocortical carcinoma cells. Conditions 
similar to those in fig.1. Basal value of cyclic GMP 
(0.84 k 0.04 pmol) has been subtracted. (B) Dose 
response of guanylate cyclase activation in adreno- 
cortical carcinoma membranes by ANF. Guanylate 
cyclase was assayed for 10 min as described [111. Results 
are shown as the mean + SE (n = 3). Basal guanylate 
cyclase activity, 68 f 3 pmol/mg protein per 10 min. 
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Fig. 1. Dose-response curve for the production of CAMP 
(A), cGMP (0) and corticosterone (m) in response to 
increasing concentrations of ANF in normal isolated 
adrenal cells. Incubation system: 0.8 ml adrenal cell 
suspension; reagens dissolved in 0.2 ml Krebs-Ringer 
bicarbonate buffer with glucose and albumin; total 
volume of incubation mixture 1.0 ml. The data 
summarize the results of 3 separate xperiments, each of 
which contain duplicate cell incubation mixtures. Basal 
values (34 k 2 ng corticosterone, 1.3 pmol cyclic GMP 
and 11 .O pmol cyclic AMP) have been subtracted. 
observed in adrenocortical carcinoma cells 
(fig.2A). In these cells, like normal adrenal cells, 
hormonally dependent particulate guanylate 
cyclase is intact [6], but the steroidogenic cyclic 
GMP signal pathway is interrupted beyond cyclic 
GMP-dependent protein kinase [12]. The ANF- 
dependent rise of cyclic GMP is rapid, with a 
detectable rise in less than 30 s (fig.3). Since the 
isolated fasciculata cells [8] and carcinoma cells [9] 
used here do not contain cyclic GMP (or cyclic 
AMP) phosphodiesterase activity [ 13,141, the 
elevations in cyclic GMP reflect ANF-dependent 
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Fig.3. Time-response curve for the formation of cGMP 
in isolated adrenocortical carcinoma cells in response to 
1 bM ANF. Conditions similar to those in fig.1. 
guanylate cyclase activities in these cells. This in- 
terpretation is supported by the observation that 
ANF directly stimulates the membrane guanylate 
cyclase (fig.ZB). 
Previously, strong evidence for the mediatory 
role of cyclic GMP in ACTH signal transduction in 
corticosterone synthesis has been provided ([15] 
and references cited therein) and it has been shown 
that in intact isolated fasciculata cells: (i) cyclic 
GMP stimulates cyclic GMP-dependent protein 
kinase and corticosterone production; (ii) cyclic 
GMP directly stimulates the transformation of 
cholesterol to corticosterone; and (iii) the 
steroidogenic potential of cyclic GMP and its 
analogues correlates closely with their ability to 
stimulate cyclic GMP-dependent protein kinase. In 
addition, cyclic GMP-dependent protein kinase 
has been purified to homogeneity, and 
biochemically characterized in bovine adrenal cor- 
tex and isolated fascicula cells of rat adrenal cortex 
VW 
Firm evidence in support of the ‘cyclic GMP 
model’ [ 151 in adrenocortical steroidogenesis came 
when the ACTH-dependent particulate guanylate 
cyclase was demonstrated in rat adrenal cortex and 
rat adrenocortical carcinoma [6,17,18]. Following 
this first demonstration of hormonally dependent 
membrane guanylate cyclase, ACTH-dependent 
membrane guanylate cyclase in neuronal cells of 
chick cerebral hemisphere [I91 and ANF- 
dependent particulate guanylate cyclase in various 
tissues have been demonstrated [5]. We anticipate 
that our present documentation of the coupling of 
ANF-receptor mediated steroidogenic signal with 
cyclic GMP in isolated fasciculata cells of rat 
adrenal cortex would pave the way for a serious 
consideration of this cyclic nucleotide as a bona 
fide second messenger in certain other hormonal 
transmembrane signal transduction pathways as 
well. 
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